[An analysis of the immunity indices of patients with iron-deficiency anemia].
The article gives an analysis of certain parameters characterizing cell-mediated and humoral immunity in patients with iron deficiency anemia (IDA). At the onset of treatment the immunologic vigor in IDA patients was characterized by a reduction in the relative number of T-lymphocytes and their helper subpopulation while after the treatments administered there was a rise in the relative numbers of B-lymphocytes against the background of presence of B-helper deficiency with the T-lymphocyte counts having returned to normal. Changes revealed in the T-lymphocyte system in IDA patients may suggest formation of early secondary immunodeficiency.
Vydyborets'
S V
SV
D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000276:immunology* / Q000628:therapy; D000917:Antibody Formation / Q000187:drug effects; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005260:Female; D005296:Ferrous Compounds / Q000008:administration & dosage; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009077:Mucins / Q000008:administration & dosage
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005296:Ferrous Compounds; D009077:Mucins; C009380:ferrous sulfate, mucin drug combination